(Q45163892)

10 December 2017

Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: a randomized placebo-controlled trial (English)

1 reference

10 December 2017

ascending cholangitis

0 references

placebo

1 reference

inferred from title

sclerosing cholangitis

1 reference

primary sclerosing cholangitis

inferred from title

1 reference

1 reference

1

1 reference

10 December 2017

Anna-Liisa Karvonen

2

1 reference

10 December 2017

Heimo Nurmi

3

1 reference

10 December 2017

Hannu Nuutinen

4

1 reference

10 December 2017

Matti Taavitsainen

5

1 reference

10 December 2017

Pekka Pikkarainen

6

1 reference

10 December 2017

Päivi Kärkkäinen

7

1 reference

10 December 2017

language of work or name

English

0 references

publication date

1 December 2004

1 reference

10 December 2017

1 reference

10 December 2017

40

1 reference

10 December 2017

6

1 reference

10 December 2017

1379-1386

1 reference

Primary sclerosing cholangitis.

10 December 2017

1 reference

HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations

21 January 2018

1 reference

Effects of antimicrobial agents on spontaneous and endotoxin-induced cytokine release of human peripheral blood mononuclear cells

21 January 2018

1 reference

Protective effect of metronidazole on uncoupling mitochondrial oxidative phosphorylation induced by NSAID: a new mechanism

21 January 2018

1 reference

The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitis.

21 January 2018

1 reference

Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders'.

21 January 2018

1 reference

High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis

21 January 2018

1 reference

Incomplete response to ursodeoxycholic acid in primary biliary cirrhosis: is a double dosage worthwhile?

21 January 2018

1 reference

Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy

21 January 2018

1 reference

Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment

21 January 2018

1 reference

Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population

21 January 2018

1 reference

Primary sclerosing cholangitis

21 January 2018

1 reference

7 January 2021

Abnormal accumulation of endotoxin in biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis

1 reference

7 January 2021

Degradation of endogenous bacterial cell wall polymers by the muralytic enzyme mutanolysin prevents hepatobiliary injury in genetically susceptible rats with experimental intestinal bacterial overgrowth

1 reference

7 January 2021

Hepatic injury associated with small bowel bacterial overgrowth in rats is prevented by metronidazole and tetracycline

1 reference

7 January 2021

Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group

1 reference

7 January 2021

A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis

1 reference

7 January 2021

Effect of long-term tetracycline therapy, steroid therapy and colectomy in pericholangitis associated with ulcerative colitis

1 reference

7 January 2021

Primary sclerosing cholangitis: value of cholangiography in determining the prognosis

1 reference

7 January 2021

Biliary lavage with corticosteroids in primary sclerosing cholangitis. A clinical, cholangiographic and bacteriological study

1 reference

7 January 2021

Oral budesonide in the treatment of primary sclerosing cholangitis

1 reference

7 January 2021

A double-blind controlled trial of oral-pulse methotrexate therapy in the treatment of primary sclerosing cholangitis

1 reference

7 January 2021

Immunomodulatory effects of ursodeoxycholic acid on immune responses

1 reference

7 January 2021

Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid

1 reference

7 January 2021

Effect of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3-year pilot study with a placebo-controlled study period

1 reference

7 January 2021

Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial

1 reference

7 January 2021

Sampling variability of percutaneous liver biopsy in primary sclerosing cholangitis

1 reference

7 January 2021

Is there a role for liver biopsy in primary sclerosing cholangitis?

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.20457

1 reference

10 December 2017

1 reference